The 2022 Digital Learning Journey on Growth Disorders

Growth disorders and short stature can severely affect the health and quality of life of children and adults. Accurate diagnosis and targeted therapy can address many cases of short stature, helping children achieve a normal adult height, alleviating both short- and long-term psychological and health issues and improving the quality of life of children and their families. Turner syndrome (TS), one of the most common sex chromosome anomalies, affects many different aspects of patient health, including
growth. Scientific Seminars 2022 live webinar will explore some of the issues of patients with TS.
Recombinant human growth hormone therapy (rhGH) has been proven to improve final adult height in patients, but timing and dosing are of paramount importance to maximize results. This event will be interactive, with healthcare professionals asked to play a pivotal role in the activity, with time for questions and answers with the audience. One of the most diagnostically challenging causes of lack of growth is genetic hypopituitarism. As different genetic mutations can interfere with growth, different clinical scenarios can complicate the diagnostic process. As the number of known mutations increases, the number of complex syndromes to consider also increases. When unknown causes for short stature can be found, idiopathic short stature can be postulated. The Scientific Seminars 2022 video interview will explore the developments in diagnosis for children with idiopathic short stature over the past 20 years, how practice has evolved with increasing knowledge and improved scientific and clinical tests.
Although the causes of lack of growth are heterogeneous, the possibilities for children with idiopathic short stature are now far improved. The 2022 Digital Learning Journey for Growth Disorders examines three aspects of growth disorders, TS, hypopituitarism and idiopathic short stature, all of which present diagnostic, clinical and therapeutic challenges to the healthcare professional in everyday practice.
Telemedicine will be used to connect medical professionals around the globe with renowned experts in the field of growth disorders to spread knowledge and best practices.

All activities will be in English.

The Live Webinar will have simultaneous translation and the Video interview subtitles into Spanish and Korean.

Upon completion of the growth disorders digital learning journey, participants will be able to:
• Describe the best timing to start rhGH therapy in Turner Syndrome with growth and maximize the results of rhGH therapy in terms of auxological and quality of life outcomes
• Identify children with ISS and select who would benefit from rhGH treatment and children who would not
• Estimate the auxological outcome of rhGH therapy
• Describe the most common causes of genetic hypopituitarism

Endocrinologists, Paediatricians, Scientists, General Practitioners, Neonatologists, Geneticists, Nurses, Nutritionists, and Healthcare Professionals involved in the diagnosis, care and follow-up of patients with growth disorders, both children and adults.

This learning journey is a structured e-learning educational program comprising:

Live webinar: The role of rhGH therapy in Turner syndrome (TS): Growth and Quality of Life
LAUNCH: 16 June 2022

Video interview: Idiopathic short stature: What has changed in the last 20 years?
LAUNCH: 15 July 2022

Congress report: ESPE 2022, Rome (15-17 September 2022)
LAUNCH: 17 October 2022

Video lecture: Novel genetic causes
LAUNCH: 15 November 2022

Share on social

EDUCATIONAL RESOURCES

Congress Report ESPE 2022 – T. Todisco
Boguszewski Margaret
Han Wook Yoo
Pfäffle Roland
Rogol Alan D.
Savage Martin
Todisco Tommaso

Annamaria Nesticò | Progamme Manager | annamaria.nestico@scientificseminars.com

This educational program is made possible thanks to an independent educational grant received from Merck Healthcare KGaA, Darmstadt, Germany.

Scientific Seminars Foundation
This website uses cookies to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of all the cookies.
Warning: some page functionalities could not work due to your privacy choices